Addus HomeCare (NASDAQ:ADUS) Price Target Lowered to $135.00 at Stephens

Addus HomeCare (NASDAQ:ADUSFree Report) had its target price reduced by Stephens from $140.00 to $135.00 in a research report released on Wednesday morning,Benzinga reports. Stephens currently has an overweight rating on the stock.

Several other research firms also recently commented on ADUS. TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Wednesday. BMO Capital Markets initiated coverage on Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 price objective on the stock. Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the company a “buy” rating in a report on Wednesday, January 7th. Finally, KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $134.33.

Get Our Latest Research Report on Addus HomeCare

Addus HomeCare Trading Up 2.3%

NASDAQ:ADUS opened at $107.60 on Wednesday. The stock has a market capitalization of $1.99 billion, a price-to-earnings ratio of 20.65, a PEG ratio of 1.26 and a beta of 0.91. The firm has a fifty day simple moving average of $109.57 and a two-hundred day simple moving average of $113.08. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $124.43.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Global Retirement Partners LLC grew its holdings in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after purchasing an additional 186 shares during the last quarter. Larson Financial Group LLC raised its holdings in shares of Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after acquiring an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC bought a new position in Addus HomeCare in the 4th quarter worth $29,000. Private Trust Co. NA raised its stake in Addus HomeCare by 65.5% in the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after buying an additional 112 shares in the last quarter. Finally, Arax Advisory Partners lifted its stake in shares of Addus HomeCare by 95.8% in the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the period. 95.35% of the stock is currently owned by institutional investors.

More Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

  • Positive Sentiment: Q4 results beat consensus on both revenue and EPS (company topped estimates). This is the primary near‑term bullish catalyst as it supports the growth and profitability narrative. ADUS Beats Q4 Estimates
  • Positive Sentiment: Management emphasized margin leverage, acquisition strategy, and expansion of personal‑care revenue on the earnings call — messaging that supports upside to margins if execution continues. Earnings Call / Strategy Highlights
  • Neutral Sentiment: Stephens lowered its price target slightly from $140 to $135 but kept an “overweight” rating, signaling conviction remains despite the trim. This is a modest negative revision but still implies significant upside from current levels. Analyst Price Target Change
  • Neutral Sentiment: Investor events: Addus will participate in the Raymond James Institutional Investors Conference, offering another forum for management to present strategy and field questions. Conference Participation
  • Negative Sentiment: Short interest rose materially in February — reported at ~1,148,513 shares (up ~23.5% from late January), representing about 6.5% of shares and a ~4.6 days‑to‑cover — increasing the risk of downward pressure or volatility if short sellers maintain exposure.
  • Negative Sentiment: Commentary pieces noted a sharp intraday decline recently (coverage discussing a ~9.45% drop), indicating some investor concern over near‑term execution or expectations that could accelerate selling pressure. Why ADUS Stock Dropped

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Read More

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.